Welcome to LookChem.com Sign In|Join Free

CAS

  • or

500024-74-8

3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

500024-74-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 500024-74-8 Structure

  • Basic information

    1. Product Name: 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE
    2. Synonyms: 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE
    3. CAS NO:500024-74-8
    4. Molecular Formula: C7H6F2N2O
    5. Molecular Weight: 172.13
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 500024-74-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 245.4±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.41±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 13.95±0.50(Predicted)
    10. CAS DataBase Reference: 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE(500024-74-8)
    12. EPA Substance Registry System: 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE(500024-74-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 500024-74-8(Hazardous Substances Data)

500024-74-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 500024-74-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,0,2 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 500024-74:
(8*5)+(7*0)+(6*0)+(5*0)+(4*2)+(3*4)+(2*7)+(1*4)=78
78 % 10 = 8
So 500024-74-8 is a valid CAS Registry Number.

500024-74-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail

  • Alfa Aesar

  • (H54636)  3,4-Difluorobenzamidoxime, 97%   

  • 500024-74-8

  • 250mg

  • 274.0CNY

  • Detail

  • Alfa Aesar

  • (H54636)  3,4-Difluorobenzamidoxime, 97%   

  • 500024-74-8

  • 1g

  • 875.0CNY

  • Detail

  • Alfa Aesar

  • (H54636)  3,4-Difluorobenzamidoxime, 97%   

  • 500024-74-8

  • 5g

  • 3646.0CNY

  • Detail

500024-74-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-DIFLUORO-N-HYDROXY-BENZAMIDINE

1.2 Other means of identification

Product number -
Other names 3,4-difluoro-N-(2-methyl-pyrimidin-5-yl)-benzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:500024-74-8 SDS

500024-74-8Upstream product

500024-74-8Relevant articles and documents

COMPOUNDS AND USES THEREOF

-

Page/Page column 118; 119, (2018/05/17)

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

AZETIDINE AMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

-

Page/Page column 46; 47, (2014/09/29)

The present invention relates to azetidine amide derivatives derivatives of formula (I) wherein rings A1 A2 and A3 are as described in the description, to pharmaceutically acceptable salts thereof, to their preparation, to

Certain Chemical Entities, Compositions, and Methods

-

Page/Page column 15-16, (2009/08/16)

Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 500024-74-8